Data presented at IDWeek 2025 after study stopped early for efficacyPrimary endpoint met, demonstrating non-inferiority of oral tebipenem HBr ...

New safety, efficacy and pharmacokinetic results presented from dose escalation portion of the studyAnti-tumour activity observed across all dose levels and in various tumour indicationsNEWCASTLE, ...

Visiting Japan is a dream for many, but it's essential to navigate the cultural landscape with sensitivity and understanding.

Simultaneous PD-1/VEGF/CTLA-4 blockade aims to compress multi-drug regimens into a single infusion, raising questions about ...

ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data showed sustained and clinically ...

Patients in cohort 9 received enfortumab vedotin at 1.25 mg/kg intravenously on days 1 and 8 plus pembrolizumab at 200 mg intravenously on day 1 of each 21-day cycle. Treatment was administered until ...

The era of the simple chatbot is over. The new wave of AI tools doesn't just answer questions—they execute entire projects.

Chairman, United Bank for Africa, UBA PLC and Founder, Tony Elumelu Foundation, Mr. Tony Elumelu, in this interview, spoke on highlights of his presentation during the seminar on Boosting Productivity ...

On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...

RAPT Therapeutics, Inc. ( NASDAQ: RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria October 20, 2025 8:30 AM EDT Good morning, and welcome to RAPT's conference ...

Viridian Therapeutics, Inc. , a biotechnology company focused on discovering, developing and commercializing potentially best-in-class medicines for serious and rare diseases, today announced it ...

To assess how government transparency branding strategy affects Small and Medium Enterprises service delivery satisfaction in Bungoma County. H01a: There is no statistically significant effect of ...